AMRX
AmnealANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
AMRX vs peer average
93/100
AMRX vs. peer average (A vs. D)
Grade spread
B 2 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
LGND is the first available peer comparator.
Similar market-cap biopharma reference, but Ligand's licensing-focused model is not directly comparable to Amneal's diversified generics, specialty, and biosimilar mix.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMRX
Amneal
LGND
Ligand
Grade
A
D
Momentum
45
35
Value
63
60
Sentiment
83
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs LGND
AMRX / LGND
Grade Position
Above peers
AMRX vs. peer average (A vs. D)
93/100
Momentum
45
AMRXValue
63
AMRXSentiment
83
AMRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMRX
LGND is the first peer returned for this comparison set.